Drugs

An innovative Ayurvedic application crafted by a team of dynamic Ayurveda experts hailing from Kerala caught the eye of attendees at the ‘Arogya Expo’ featured during the World Ayurveda Congress held recently in Dehradun, Uttarakhand. Called ‘Bhishak,’ this app offers […]

The chairperson of Biocon Group, Kiran Mazumdar-Shaw, has been awarded the renowned Jamsetji Tata Award by the Indian Society for Quality (ISQ). This accolade recognizes her groundbreaking role in advancing the biosciences movement within India and her dedication to serving

Glenmark Pharmaceuticals Inc., USA has unveiled the lacosamide oral solution at a concentration of 10 mg/mL. This product matches the bioequivalence and therapeutic effects of the reference drug, Vimpat Oral Solution at the same strength, originally produced by UCB, Inc.

Indian Military Procurement Notice Goods Healthcare and Medicine GEM Jammu, Jammu & Kashmir Opening Date 11 Dec 2024 Closing Date 1 Jan 2025 Tender Amount ? 9,49,868  Costs EMD Refer to Documents Document Fee Consult Documents Application Fee Check Documentation Details

North Central Railway Tender – NCR Goods Healthcare and Medicine Kanpur Nagar, Uttar Pradesh Start Date 13 Dec 2024 End Date 10 Jan 2025 Estimated Tender Amount ₹ 5,00,000 Costs and Fees EMD 0 Document Cost See Documents Tender Fee See

Nyxoah SA (Nyxoah), a pioneering medical technology firm, recently launched its innovative Genio system in England to address obstructive sleep apnoea (OSA) with neuromodulation techniques. This commercial introduction was celebrated with the initial successful procedures at University College London Hospitals

The advent of immune checkpoint inhibitors has transformed the treatment landscape for several advanced cancers, yet a plateau in therapeutic response has emerged due to resistance, impairing tumor-infiltrating lymphocytes (TILs). To counteract this resistance and revitalize anti-cancer TILs, which are

Neurocrine Biosciences, Inc., recognized for its neuroscience innovations, has announced the U.S. Food and Drug Administration’s endorsement of Crenessity (crinecerfont) as a supplementary therapy to glucocorticoid replacement. This approval is for the purpose of controlling androgen levels in adults and

Zimmer Biomet Holdings, Inc., a pioneer in medical technology worldwide, announced that their OsseoFit Stemless Shoulder System has received 510(k) clearance from the US Food and Drug Administration (FDA) for use in total shoulder replacement procedures. This state-of-the-art implant is

Following their recent agreement to tackle rabies, specifically in Machakos County, Boehringer Ingelheim and Vétérinaires sans Frontières Germany (VSF Germany) are enhancing their longstanding partnership. This collaboration features vaccination campaigns, community education initiatives, and teaching programs within schools. Boehringer Ingelheim